• About us
• Contact

Advertisement

Organisation › Details

NexMR GmbH

NexMR GmbH is an innovative technology company dedicated to revolutionizing fragment-based drug discovery. Leveraging advanced nuclear magnetic resonance (NMR) techniques, NexMR provides efficient solutions for fragment screening and lead optimization. Their cutting-edge platform enables researchers to accelerate the development of novel therapeutics. *

 

	Start	2022-05-31 established (s-off)
	Predecessor	ETH Zürich (ETHZ)
	Industry	drug discovery technology
	Industry 2	NMR spectroscopy
	Person	Torres Hubiche, Félix (NexMR 202307 CEO + Co-Founder)
	Region	Schlieren ZH
	Country	Switzerland
	Street	10A Wiesenstr.
	City	8952 Schlieren ZH
		Address record changed: 2023-12-19
Basic data	Employees	n. a.
		* Document for »About Section«: CrystalsFirst GmbH. (7/24/23). "Press Release: CrystalsFirst and NexMR Join Forces to Supercharge Fragment-based Drug Discovery".
		Record changed: 2026-05-02

Advertisement

More documents for NexMR GmbH

• [1] CrystalsFirst GmbH. (7/24/23). "Press Release: CrystalsFirst and NexMR Join Forces to Supercharge Fragment-based Drug Discovery"....

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2026. Made in Germany.